Beranda › Amiloidosis › Texas
Uji klinis Amiloidosis di Texas
11 studi untuk Amiloidosis mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Dallas
- Research Site, Houston
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Austin
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Dallas
- Clinical Trial Site, Houston
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Dallas
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07358078ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, Austin
- Clinical Trial Site, Houston
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- University of Texas Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
- UT Southwestern Medical Center, Dallas
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- National Neuromuscular Research Institute, Austin
- University of Texas Southwestern, Dallas
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern Medical Center, Dallas
- Baylor College of Medicine, Houston
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
- UT Southwestern Medical Center, Dallas
Menerima pesertaStudi observasional
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT07196839Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.